Clinical trial
Tazemetostat Expanded Access Program for Adults With Solid Tumors
NCT03874455
Study timeline
Registry last updated2026-07-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Epithelioid Sarcoma (Ex-US Only)unresolved
Thoracic Sarcomaunresolved
ATRTverified · MONDO: atypical teratoid rhabdoid tumor
Malignant Rhabdoid Tumor of Ovaryunresolved
Myxoid Spindle Cell Sarcomaunresolved
Chondrosarcomaverified · MONDO: chondrosarcoma
Synovial Sarcomaverified · MONDO: synovial sarcoma
Interventions
TazemetostatDRUG · verified · RxNorm: tazemetostat
Sponsors & collaborators
Epizyme, Inc.lead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03874455 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.